CTNNBL1

Beta-catenin-like protein 1 · Q8WYA6 · CTNNBL1 on Sugi Atlas →

0 patent compounds predicted against CTNNBL1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CTNNBL1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome PHASE1/PHASE2RECRUITING
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer PHASE2ACTIVE_NOT_RECRUITING
Mesalazine Effects in Sporadic Colorectal Adenoma Patients PHASE2COMPLETED
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma PHASE1RECRUITING
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma PHASE1COMPLETED
Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors PHASE1COMPLETED
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors PHASE1RECRUITING
Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma EARLY_PHASE1RECRUITING
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study nanCOMPLETED
Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation nanCOMPLETED
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION nanRECRUITING
Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial nanNOT_YET_RECRUITING
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury nanUNKNOWN
Klotho _ LRP-6 _ Gastric Adenocarcinoma nanUNKNOWN
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma. nanRECRUITING
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment nanCOMPLETED
CTNNB1 Neurodevelopmental Syndrome - Natural History Study nanRECRUITING
Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins nanCOMPLETED
Effect of Non-Surgical Periodontal Therapy on Salivary Biomarkers in Smokers and Non-Smokers With Periodontitis nanRECRUITING
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients nanCOMPLETED
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer nanCOMPLETED
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers nanRECRUITING
CTNNA1 Familial Expansion Study nanRECRUITING
Tension-Type Headache Gene Expression and Methylation nanAVAILABLE
Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Precision-Based Genomics in Prostate Cancer nanRECRUITING
Hyperekplexia in Patients With CTNNB1 Mutation nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CTNNBL1 binder may also engage these)

ProteinNameSimilarity
O62703 1.000 O62703 →
Q9CWL8 1.000 Q9CWL8 →
Q4V8K2 0.996 Q4V8K2 →
F4J738 0.971 F4J738 →
Q5ZMW3 0.970 Q5ZMW3 →
Q5R644 0.969 Q5R644 →
Q5R882 0.968 Q5R882 →
Q6QI06 0.967 Q6QI06 →
Q5E993 0.967 Q5E993 →
F4IRR2 0.967 F4IRR2 →
Q9CRD2 0.967 Q9CRD2 →
Q56A27 0.966 Q56A27 →
A2AT37 0.966 A2AT37 →
O35841 0.966 O35841 →
P41542 0.966 P41542 →
Q9HAU5 0.965 Q9HAU5 →
Q6GQD0 0.965 Q6GQD0 →
Q6TGY8 0.965 Q6TGY8 →
Q6GQ80 0.965 Q6GQ80 →
P41541 0.965 P41541 →
Q9FGK3 0.965 Q9FGK3 →
VPS35 Vacuolar protein sorting-associated protein 35 0.965 landscape →
Q5F3U9 0.965 Q5F3U9 →
API5 Apoptosis inhibitor 5 0.964 landscape →
Q8BHL5 0.964 Q8BHL5 →
RICTOR Rapamycin-insensitive companion of mTOR 0.964 landscape →
Q803T2 0.964 Q803T2 →
Q9EQH3 0.964 Q9EQH3 →
USO1 General vesicular transport factor p115 0.964 landscape →
Q9Z1Z0 0.964 Q9Z1Z0 →